These compounds may reveal interesting therapeutic properties, such as attenuation of body weight gain and amelioration of glucose-insulin homeostasis in a mouse model of HFD-induced obesity after administration of THCA [73]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.